Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh

As of December 31, 2025, Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh carries a market capitalization of 491.05M, placing it among publicly traded companies globally. Its enterprise value stands at 468.86M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh's next confirmed earnings release is scheduled for December 2, 2026.

As of December 31, 2025, Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh has 320.95M shares outstanding.

These figures are as of December 31, 2025. The price-to-sales ratio is 1,078.73, and the price-to-book ratio stands at 28.45.

These figures are as of December 31, 2025. The EV/Sales ratio of 1,070.67 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 468.86M versus a market cap of 491.05M, with the gap driven by net debt and cash on the balance sheet.

As of December 31, 2025, Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh maintains a current ratio of 2.47, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 225.33, indicating elevated leverage, while an interest coverage ratio of -5,475.07 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended December 31, 2025. Return on assets (ROA) is negative at -75.15, reflecting losses generated across the asset base. Inventory turnover of 1.79 indicates how many times Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 22, 2026, Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh's stock has declined approximately 8.22% over the past 52 weeks. The 50-day moving average sits at 1.73, while the 200-day moving average is 1.85.

Over the twelve months ended December 31, 2025, Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh generated 437,908.11 in revenue and converted that into -37.93M in net income, yielding earnings per share of -0.12. EBITDA reached -34.19M, while operating income came in at -35.39M.

As of December 31, 2025, Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh holds 61.09M in cash and equivalents against 38.90M in total debt, resulting in a net debt position of 8.26M. Total book value stands at 17.26M, with working capital of 38.27M providing operational flexibility.

These figures cover the twelve months ended December 31, 2025.

Over the twelve months ended December 31, 2025, Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh posted a gross margin of -695.68, reflecting its pricing power and cost economics. The operating margin of -8,081.95 and net profit margin of -8,661.57 provide insight into operational efficiency.

These figures cover the twelve months ended December 31, 2025. Total shareholder yield is negative at -13.13, meaning Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh's most recent stock split took place on February 5, 2024 with a 675:697 split ratio.

As of December 31, 2025, Imricor Medical Systems, Inc. Shs Chess Depository Interests Repr 1 Sh has an Altman Z-Score of -0.41, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.